Novartis Appeals Suit to Block FDA Approval of Rival Entresto

Novartis AG is appealing the denial of its request for immediate injunctive relief after the FDA’s approval of a generic version of its heart failure drug Entresto.

The drugmaker’s notice of appeal to the US Court of Appeals for the District of Columbia Circuit comes after a federal judge in Washington denied without prejudice Novartis’ motion for a temporary restraining order or preliminary injunction against the Food and Drug Administration’s greenlight of a generic version of Entresto manufactured by MSN Laboratories.

Novartis alleged the FDA unlawfully approved MSN’s generic of Entresto, but the agency claimed Novartis is unlikely to ...